Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001379272 | SCV001577043 | likely pathogenic | not provided | 2022-07-27 | criteria provided, single submitter | clinical testing | This variant is not present in population databases (gnomAD no frequency). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 2362). This missense change has been observed in individual(s) with retinitis pigmentosa (PMID: 17296898, 31456290). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. This sequence change replaces arginine, which is basic and polar, with glycine, which is neutral and non-polar, at codon 4674 of the USH2A protein (p.Arg4674Gly). |
OMIM | RCV000002458 | SCV000022616 | pathogenic | Retinitis pigmentosa 39 | 2007-02-01 | no assertion criteria provided | literature only | |
Gene |
RCV000032522 | SCV000056185 | not provided | Retinitis pigmentosa | no assertion provided | literature only | ||
Sharon lab, |
RCV000032522 | SCV001161334 | likely pathogenic | Retinitis pigmentosa | 2019-06-23 | no assertion criteria provided | research |